Expression of a novel alternatively spliced variant of NADP(H)-dependent retinol dehydrogenase/reductase with deletion of exon 3 in cervical squamous carcinoma

International Journal of Cancer

Volumn 120, Issue 8, 2007, Pages 1618-1626

  Song, Xu Hong ^a   Liang, Bin ^a   Liu, Ge Fei ^a   Li, Rui ^a   Xie, Jian Ping ^a   Du, Kun ^a   Huang, Dong Yang ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Alternative splicing; Cervical squamous carcinoma; NRDR; Tumorigenesis

Indexed keywords

MESSENGER RNA; PROTEIN NRDR; PROTEIN NRDRB 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RETINAL; RETINOIC ACID; RETINOID; RETINOL DEHYDROGENASE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CARCINOGENESIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EXON; FEMALE; GENE DELETION; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLIC DISORDER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA;

ALCOHOL OXIDOREDUCTASES; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; CARCINOMA, SQUAMOUS CELL; EXONS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; IMMUNOBLOTTING; MOLECULAR SEQUENCE DATA; NADP; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE DELETION; SEQUENCE HOMOLOGY, AMINO ACID; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VARIATION (GENETICS);

EID: 33947107526     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22306     Document Type: Article

References (48)

1. Huang DY, Ichikawa Y. Purification and characterization of a novel cytosolic NADP (H)-dependent retinol oxidoreductase from rabbit liver. Biochem Biophys Acta 1997;1338:47-59.
2. Usami N, Ishikura S, Abe H, Nagano M, Uebuchi M, Kuniyasu A, Otagiri M, Nakayama H, Imamura Y, Hara A. Cloning, expression and tissue distribution of a tetrameric form of pig carbonyl reductase. Chem Biol Interact 2003;143-144:353-61.
3. Du J, Huang DY, Liu GF, Wang GL, Xu XL, Wang B, Zhu L. cDNA cloning of a short isoform of human liver NADP (H)-dependent retinol dehydrogenase/reductase and analysis of its characteristics. Acta Genetica Sinica 2004;31:661-7.
4. Lei Z, Chen W, Zhang M, Napoli JL. Reduction of all-trans-retinal in the mouse liver peroxisome fraction by the short-chain dehydrogenase/reductase RRD: induction by the PPAR α ligand clofibrate. Biochemistry 2003;42:4190-6.
5. Liu GF, Huang DY, Du J, Cui ZS, Song JD. Functional expression of NADP (H)-dependent retinol dehydrogenase/reductase and determination of its subcellular localization. Chin J Cell Biol 2004;26:433-8.
6. Napoli JL. Retinoic acid biosynthesis and metabolism. FASEB J 1996; 10:993-1001.
7. Duester G. Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur J Biochem 2000;267:4315-24.
8. Ulven SM, Gundersen TE, Weedon MS, Landaas VO, Sakhi AK, Fromm SH, Geronimo BA, Moskaug JO, Blomhoff R. Identification of endogenous retinoids, enzymes, binding proteins, and receptors during early postimplantation development in mouse: important role of retinal dehydrogenase type 2 in synthesis of all-transretinoic acid. Dev Biol 2000;220:379-91.
9. Huang DY, Ichikawa Y. Two different enzymes are primarily responsible for retinoic acid synthesis in rabbit liver cytosol. Biochem Biophys Res Commun 1994;205:1278-83.
10. Molotkov A, Fan X, Duester G. Excessive vitamin A toxicity in mice genetically deficient in either alcohol dehydrogenase Adh1 or Adh3. Eur J Biochem 2002;269:2607-12.
11. Freemantle SJ, Spinella MJ, Dmitrovsky E. Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 2003; 22:7305-15.
12. Okuno M, Kojima S, Matsushima-Nishiwaki R, Tsurumi H, Muto Y, Friedman SL, Moriwaki H. Retinoids in cancer chemoprevention. Curr Cancer Drug Targets 2004;4:285-98.
13. Um SJ, Han HS, Kwon YJ, Park SH, Rho YS, Sin HS, Park JS. Novel retinoic acid derivative ABPN has potent inhibitory, activity on cell growth and apoptosis in cancer cells. Int J Cancer 2003;107:1038-46.
14. Drisko JA, Chapman J, Hunter VJ. The use of antioxidant therapies during chemotherapy. Gynecol Oncol 2003;88:434-9.
15. Wendy JH, Lihua L, Roberto JB, Karen KH, Norman MG. Retinoic acid slows progression and promotes apoptosis of spontaneous prostate cancer. Prostate 2004;61:142-52.
16. Romney SL, Palan PR, Duttagupta C, Wassertheil-Smolter S, Wylie J, Miller G, Slagle NS, Lucido D. Retinoids and prevention of cervical dysplasia. Am J Obstet Gynecol 1981;141:890-4.
17. Rafael MY, Wen LZ, Yuvarani SK, Brent R, Yongkui J, David EO. Retinol conversion to retinoic acid is impaired in breast cancer cell lines relative to normal cells. J Cell Physiol 2000;185:302-9.
18. Ngan HY, Collins RJ, Wong KY, Cheung A, Lai CF, Liu YT. Cervical human papilloma virus infection of women attending social hygiene clinics in Hong Kong. Int J Gynecol Obstet 1993;41:75-9.
19. Francois M, Pilar G, Pierre D, Isabelle B, Pastelle K, Sandrine B, Carla E, Serge H. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trail. Int J Cancer 2005;116:182-6.
20. Li YF, Liu GF, Song XH, Du K, Huang DY. cDNA cloning of a short isoform of human neuroblastoma NADP (H)-dependent retinol dehydrogenase/reductase and analysis of its characteristics. Teratog Carcinog Mutagen 2005;17:321-6.
21. Faustino NA, Cooper TA. Pre-mRNA splicing and human disease. Genes Dev 2003;17:419-37.
22. Garcia-Blanco MA, Baraniak AP, Lasda EL. Alternative splicing in disease and therapy. Nat Biotechnol 2004;22;535-46.
23. Black DL. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 2003;72:291-336.
24. Maniatis T, Tasic B. Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature 2002;418:236-43.
25. Grabowski PJ, Black DL. Alternative RNA splicing in the nervous system. Prog Neurobiol 2001;65:289-308.
26. Venables JP. Alternative splicing in the testes. Curr Opin Genet Dev 2002;12:615-9.
27. Brett D, Hanke J, Lehmann G, Haase S, Delbruck S, Krueger S, Reich J, Bork P. EST comparison indicates 38% of human mRNAs contain possible alternative splice forms. FEBS Lett 2000;474:83-6.
28. Xu Q, Lee C. Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. Nucleic Acids Res 2003;31:5635-43.
29. Wang Z, Lo HS, Yang H, Gere S, Hu Y, Buetow KH, Lee MP. Computational analysis and experimental validation of tumorassociated alternative RNA splicing in human cancer. Cancer Res 2003;63:655-57.
30. Recio JA, Merlino G. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1. Cancer Res 2003;63:1576-82.
31. Line A, Slucka Z, Stengrevics A, Li G, Rees RC. Altered splicing pattern of TACC1 mRNA in gastric cancer. Cancer Genet Cytogenet 2002;139:78-83.
32. Matsumoto R, Tada M, Nozaki M, Zhang CL, Sawamura Y, Abe H. Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasm. Cancer Res 1998;58: 609-13.
33. Asai DJ. Methods in cell biology, vol. 37. San Diego: Academic Press, 1993. 19-50.
34. Parkin DM, Pisani P, Folay J. Estimates of the worldwide incidence of 18 major cancers in 1985. Int J Cancer 1993;54:594-606.
35. Monsonego J, Bosch FX, Coursaget P, Cox JT, Franco E, Frazer I, Sankaranarayanan R, Schiller J, Singer A, Wright TC, Jr, Kinney W, Meijer CJ, et al. Cervical cancer control, priorities and new directions. Int J Cancer 2004;108:329-33.
36. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
37. Beskow AH, Engelmark MT, Magnusson JJ, Gyllensten UB. Interaction of host and viral risk factors for development of cervical carcinoma in situ. Int J Cancer 2005;117:690-2.
38. Choo CK, Rorke EA, Eckert RL. Retinoid regulation of cell differentiation in a series of human papillomavirus type 16-immortalized human cervical epithelial cell lines. Carcinogenesis 1995;16:375-81.
39. Agarwal C, Rorke EA, Irwin JC, Eckert RL. Immortalization by human papillomavirus type 16 alters retinoid regulation of human ecto-cervical epithelial cell differentiation. Cancer Res 1991;51:3982-9.
40. Gasowska-Giszczak U, Darmochwal-Kolarz D, Kwasniewska A, Dziubinska-Parol I, Rolinski J, Oleszczuk J. Apoptosis of HeLa cell lines incubated with retinol. Eur J Obstet Gynecol Reprod Biol 2005; 119:119-22.
41. Okada S, Kao AW, Ceresa BP, Blaikie P, Margolis B, Pessin JE. The 66-kDa Shc isoform is a negative regulator of the epidermal growth factor-stimulated mitogen-activated protein kinase pathway. J Biol Chem 1997;272:28042-9.
42. Srinivasula SM, Ahmas M, Guo Y, Zhan Y, Lazebnik Y, Fernandes-Alnemri T, Alnemri ES. Identification of an endogenous dominant-negative short isoform of caspase-9 that can regulate apoptosis. Cancer Res 1999;59:999-1002.
43. Garneau D, Revil T, Fisette JF, Chabot B. Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x. J Biol Chem 2005;280:22641-50.
44. Kalnina Z, Zayakin P, Silina K, Line A. Alterations of pre-mRNA splicing in cancer. Genes Chromosomes Cancer 2005;42:342-57.
45. Venables JP. Aberrant and alternative splicing in cancer. Cancer Res 2004;64:7647-54.
46. Sun SY, Lotan R. Retinoids and their receptors in cancer development and chemoprevention. Crit Rev Oncol Hematol 2002;41:41-55.
47. Reina GC, Xavier CE, Xavier B, Carlos AG. The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int J Cancer 2005;117:629-37.
48. Sporn MB, Roberts AB, Goodman DS, eds. The retinoids: biology, chemistry and medicine. New York: Raven, 1994. 229-50.